Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study

ObjectiveA 2-dose varicella vaccine immunization strategy has been implemented in many cities in China, but there is few evidence on a long-term evaluation of the efficacy of the 2-dose varicella vaccine from China. This study aims to assess the long-term vaccine efficacy of the two doses varicella...

Full description

Bibliographic Details
Main Authors: Mingming Shu, Dandan Zhang, Rui Ma, Tianchi Yang, Xingqiang Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1039537/full
_version_ 1797988942991065088
author Mingming Shu
Dandan Zhang
Rui Ma
Tianchi Yang
Xingqiang Pan
author_facet Mingming Shu
Dandan Zhang
Rui Ma
Tianchi Yang
Xingqiang Pan
author_sort Mingming Shu
collection DOAJ
description ObjectiveA 2-dose varicella vaccine immunization strategy has been implemented in many cities in China, but there is few evidence on a long-term evaluation of the efficacy of the 2-dose varicella vaccine from China. This study aims to assess the long-term vaccine efficacy of the two doses varicella vaccine and analysis of its influencing factors.MethodsA retrospective study was carried out in 837,144 children born between 2011 and 2017 in Ningbo, Easten China. The logistic regression was performed to estimate varicella vaccine effectiveness (VE).ResultsThe overall VE of 2 doses of varicella vaccine compared without the vaccine was 90.31% (89.24–91.26%), and the overall incremental VE of 2 doses of varicella vaccine compared to the 1-dose was 64.71% (59.92–68.93%). Moreover, the varicella vaccination age of the second dose and the interval between 2 doses were both associated with VE. The VE compared to that without the vaccine in children vaccinated at <4 years old was 91.22% (95%CI: 90.16–92.17%) which was higher than in children vaccinated at ≥4 years old (VE: 86.79%; 95%CI: 84.52–88.73). And the effectiveness of the vaccine was 93.60% (95%CI: 92.19–94.75%) in children with the interval of the 2 doses ≤ 24 months significantly higher than in children with the interval of ≥36 months (VE: 85.62%, 95%CI: 82.89–87.91%).ConclusionsThis study provides evidence for long-term VE of the 2-dose varicella vaccine and the better age for 2-dose vaccination and the interval between 2 doses of the vaccine in China.
first_indexed 2024-04-11T08:11:14Z
format Article
id doaj.art-24a863b43f6f47c496e1bb39f3a69f8b
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-11T08:11:14Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-24a863b43f6f47c496e1bb39f3a69f8b2022-12-22T04:35:19ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-11-011010.3389/fpubh.2022.10395371039537Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational studyMingming Shu0Dandan Zhang1Rui Ma2Tianchi Yang3Xingqiang Pan4Ningbo Women and Children's Hospital, Ningbo, ChinaNingbo Municipal Center for Disease Control and Prevention, Ningbo, ChinaNingbo Municipal Center for Disease Control and Prevention, Ningbo, ChinaNingbo Municipal Center for Disease Control and Prevention, Ningbo, ChinaNingbo Municipal Center for Disease Control and Prevention, Ningbo, ChinaObjectiveA 2-dose varicella vaccine immunization strategy has been implemented in many cities in China, but there is few evidence on a long-term evaluation of the efficacy of the 2-dose varicella vaccine from China. This study aims to assess the long-term vaccine efficacy of the two doses varicella vaccine and analysis of its influencing factors.MethodsA retrospective study was carried out in 837,144 children born between 2011 and 2017 in Ningbo, Easten China. The logistic regression was performed to estimate varicella vaccine effectiveness (VE).ResultsThe overall VE of 2 doses of varicella vaccine compared without the vaccine was 90.31% (89.24–91.26%), and the overall incremental VE of 2 doses of varicella vaccine compared to the 1-dose was 64.71% (59.92–68.93%). Moreover, the varicella vaccination age of the second dose and the interval between 2 doses were both associated with VE. The VE compared to that without the vaccine in children vaccinated at <4 years old was 91.22% (95%CI: 90.16–92.17%) which was higher than in children vaccinated at ≥4 years old (VE: 86.79%; 95%CI: 84.52–88.73). And the effectiveness of the vaccine was 93.60% (95%CI: 92.19–94.75%) in children with the interval of the 2 doses ≤ 24 months significantly higher than in children with the interval of ≥36 months (VE: 85.62%, 95%CI: 82.89–87.91%).ConclusionsThis study provides evidence for long-term VE of the 2-dose varicella vaccine and the better age for 2-dose vaccination and the interval between 2 doses of the vaccine in China.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1039537/fullvaricellavaccine effectivenessvaricella vaccineepidemiologyvaccine immunization strategy
spellingShingle Mingming Shu
Dandan Zhang
Rui Ma
Tianchi Yang
Xingqiang Pan
Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study
Frontiers in Public Health
varicella
vaccine effectiveness
varicella vaccine
epidemiology
vaccine immunization strategy
title Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study
title_full Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study
title_fullStr Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study
title_full_unstemmed Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study
title_short Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study
title_sort long term vaccine efficacy of a 2 dose varicella vaccine in china from 2011 to 2021 a retrospective observational study
topic varicella
vaccine effectiveness
varicella vaccine
epidemiology
vaccine immunization strategy
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.1039537/full
work_keys_str_mv AT mingmingshu longtermvaccineefficacyofa2dosevaricellavaccineinchinafrom2011to2021aretrospectiveobservationalstudy
AT dandanzhang longtermvaccineefficacyofa2dosevaricellavaccineinchinafrom2011to2021aretrospectiveobservationalstudy
AT ruima longtermvaccineefficacyofa2dosevaricellavaccineinchinafrom2011to2021aretrospectiveobservationalstudy
AT tianchiyang longtermvaccineefficacyofa2dosevaricellavaccineinchinafrom2011to2021aretrospectiveobservationalstudy
AT xingqiangpan longtermvaccineefficacyofa2dosevaricellavaccineinchinafrom2011to2021aretrospectiveobservationalstudy